15111373

Source:http://linkedlifedata.com/resource/pubmed/id/15111373

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023779, umls-concept:C0043210, umls-concept:C0232970, umls-concept:C0244404, umls-concept:C0262950, umls-concept:C1136013, umls-concept:C1280500, umls-concept:C1707455
pubmed:issue	8
pubmed:dateCreated	2004-4-27
pubmed:abstractText	Although many studies have assessed the effects of estrogen and raloxifene hydrochloride on bone mineral density and serum lipid concentrations, there are few direct comparative data.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0372440
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Collagen, http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I, http://linkedlifedata.com/resource/pubmed/chemical/Estrogen Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, http://linkedlifedata.com/resource/pubmed/chemical/Estrogens, Conjugated (USP), http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Osteocalcin, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Raloxifene, http://linkedlifedata.com/resource/pubmed/chemical/collagen type I trimeric...
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0003-9926
pubmed:author	pubmed-author:AdachiJonathon DJD, pubmed-author:CiacciaAngelina VAV, pubmed-author:DraperMichael WMW, pubmed-author:EastellRichardR, pubmed-author:FogelmanIgnacI, pubmed-author:NetelenbosCoenC, pubmed-author:ReidIan RIR, pubmed-author:RosenAmyA, pubmed-author:SeemanEgoE, pubmed-author:WattsNelson BNB
pubmed:issnType	Print
pubmed:day	26
pubmed:volume	164
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	871-9
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15111373-Alkaline Phosphatase, pubmed-meshheading:15111373-Bone Density, pubmed-meshheading:15111373-Bone and Bones, pubmed-meshheading:15111373-Cholesterol, pubmed-meshheading:15111373-Cholesterol, HDL, pubmed-meshheading:15111373-Collagen, pubmed-meshheading:15111373-Collagen Type I, pubmed-meshheading:15111373-Double-Blind Method, pubmed-meshheading:15111373-Estrogen Antagonists, pubmed-meshheading:15111373-Estrogens, pubmed-meshheading:15111373-Estrogens, Conjugated (USP), pubmed-meshheading:15111373-Female, pubmed-meshheading:15111373-Humans, pubmed-meshheading:15111373-Hysterectomy, pubmed-meshheading:15111373-Lipids, pubmed-meshheading:15111373-Lipoproteins, pubmed-meshheading:15111373-Middle Aged, pubmed-meshheading:15111373-Osteocalcin, pubmed-meshheading:15111373-Peptides, pubmed-meshheading:15111373-Raloxifene
pubmed:year	2004
pubmed:articleTitle	A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
pubmed:affiliation	Department of Medicine, University of Auckland, PB 92019, Auckland, New Zealand. i.reid@auckland.ac.nz
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III